• According to estimates from 16 analysts, Zimmer Biomet Holdings, Inc. stock's average price target has risen from $101.89 to $102.88, with forecasts ranging from $83 to $115 per share
  • Based on the Aug. 5 closing price, the updated target implies approximately 5% potential upside
  • Consensus rating remains at “Buy” across 23 covering analysts, with 7 Buys, 16 Holds and 0 Sells

Explore more price target data and ratings for Zimmer Biomet Holdings, Inc. on the , and track all previous and future analyst recommendations for Zimmer Biomet Holdings, Inc. in the dedicated .

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.